1
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
796,106
$53.2m31.82%
31.82%
Added Shares held: Q3 2020 794.4k, Q4 2020 794.4k, Q1 2021 794.2k, Q2 2021 796.1k
+1.9k
+1,920
0.2%
2
ACCELERATE DIAGNOSTICS INC
COM
COM
2,232,857
$18.0m10.74%
10.74%
Added Shares held: Q3 2020 2.2m, Q4 2020 2.2m, Q1 2021 2.2m, Q2 2021 2.2m
+19.5k
+19,531
0.9%
3
BIODESIX INC
COM
COM
1,104,953
$14.6m8.73%
8.73%
Unchanged Shares held: Q3 2020 0, Q4 2020 1.1m, Q1 2021 1.1m, Q2 2021 1.1m
4
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
80,200
$7.8m4.67%
4.67%
Unchanged Shares held: Q3 2020 78.0k, Q4 2020 80.2k, Q1 2021 80.2k, Q2 2021 80.2k
5
QUIDEL CORP
COM
QDEL
QDEL
59,684
$7.6m4.57%
4.57%
Added Shares held: Q3 2020 58.6k, Q4 2020 58.6k, Q1 2021 58.6k, Q2 2021 59.7k
+1.0k
+1,040
1.8%
6
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
199,400
$4.9m2.91%
2.91%
Added Shares held: Q3 2020 102.0k, Q4 2020 102.0k, Q1 2021 177.0k, Q2 2021 199.4k
+22.4k
+22,400
12.7%
7
BIOGEN INC
COM
BIIB
BIIB
12,100
$4.2m2.51%
2.51%
Unchanged Shares held: Q3 2020 11.0k, Q4 2020 12.1k, Q1 2021 12.1k, Q2 2021 12.1k
8
ALBIREO PHARMA INC
COM
BIOD
BIOD
111,000
$3.9m2.34%
2.34%
Unchanged Shares held: Q3 2020 58.0k, Q4 2020 92.0k, Q1 2021 111.0k, Q2 2021 111.0k
9
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
314,143
$3.4m2.01%
2.01%
Unchanged Shares held: Q3 2020 0, Q4 2020 314.1k, Q1 2021 314.1k, Q2 2021 314.1k
10
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
18,000
$3.2m1.93%
1.93%
Unchanged Shares held: Q3 2020 18.0k, Q4 2020 18.0k, Q1 2021 18.0k, Q2 2021 18.0k
11
KARYOPHARM THERAPEUTICS INC
COM
COM
230,000
$2.4m1.42%
1.42%
Unchanged Shares held: Q3 2020 168.0k, Q4 2020 188.0k, Q1 2021 230.0k, Q2 2021 230.0k
12
BLUEBIRD BIO INC
COM
COM
74,000
$2.4m1.42%
1.42%
Reduced Shares held: Q3 2020 60.0k, Q4 2020 62.0k, Q1 2021 75.5k, Q2 2021 74.0k
-1.5k
-1,500
-2.0%
13
ACCELERON PHARMA INC
COM
XLRN
XLRN
18,672
$2.3m1.40%
1.40%
Unchanged Shares held: Q3 2020 18.7k, Q4 2020 18.7k, Q1 2021 18.7k, Q2 2021 18.7k
14
MASIMO CORP
COM
MASI
MASI
8,000
$1.9m1.16%
1.16%
Unchanged Shares held: Q3 2020 8.0k, Q4 2020 8.0k, Q1 2021 8.0k, Q2 2021 8.0k
15
ANGION BIOMEDICA CORP
COM
COM
60,615
$1.9m1.16%
1.16%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 60.6k, Q2 2021 60.6k
16
VANDA PHARMACEUTICALS INC
COM
VNDA
VNDA
80,000
$1.7m1.03%
1.03%
Unchanged Shares held: Q3 2020 80.0k, Q4 2020 80.0k, Q1 2021 80.0k, Q2 2021 80.0k
17
HARROW INC
COM
HROW
HROW
180,000
$1.7m1.00%
1.00%
Unchanged Shares held: Q3 2020 180.0k, Q4 2020 180.0k, Q1 2021 180.0k, Q2 2021 180.0k
18
PROTHENA CORP PLC
SHS
PRTA
PRTA
30,247
$1.6m0.93%
0.93%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 30.2k
19
ARENA PHARMACEUTICALS INC
COM NEW
ARNA
ARNA
22,000
$1.5m0.90%
0.90%
Unchanged Shares held: Q3 2020 22.0k, Q4 2020 22.0k, Q1 2021 22.0k, Q2 2021 22.0k
20
CONTINENTAL RES INC
COM
CLR
CLR
38,600
$1.5m0.88%
0.88%
Unchanged Shares held: Q3 2020 38.6k, Q4 2020 38.6k, Q1 2021 38.6k, Q2 2021 38.6k
21
AMARIN CORP PLC
SPONS ADR NEW
SPONS ADR NEW
300,000
$1.3m0.79%
0.79%
Unchanged Shares held: Q3 2020 300.0k, Q4 2020 300.0k, Q1 2021 300.0k, Q2 2021 300.0k
22
IMMUNOGEN INC
COM
IMGN
IMGN
190,000
$1.3m0.75%
0.75%
Unchanged Shares held: Q3 2020 190.0k, Q4 2020 190.0k, Q1 2021 190.0k, Q2 2021 190.0k
23
NEKTAR THERAPEUTICS
COM
COM
72,000
$1.2m0.74%
0.74%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 92.0k, Q2 2021 72.0k
-20.0k
-20,000
-21.7%
24
ALKERMES PLC
SHS
ALKS
ALKS
50,000
$1.2m0.73%
0.73%
Added Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 35.0k, Q2 2021 50.0k
+15.0k
+15,000
42.9%
25
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
45,114
$1.2m0.70%
0.70%
Reduced Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 60.1k, Q2 2021 45.1k
-15.0k
-15,000
-24.9%
26
ARVINAS INC
COM
ARVN
ARVN
15,000
$1.2m0.69%
0.69%
Unchanged Shares held: Q3 2020 15.0k, Q4 2020 15.0k, Q1 2021 15.0k, Q2 2021 15.0k
27
EQUITRANS MIDSTREAM CORP
COM
ETRN
ETRN
133,050
$1.1m0.68%
0.68%
Unchanged Shares held: Q3 2020 133.1k, Q4 2020 133.1k, Q1 2021 133.1k, Q2 2021 133.1k
28
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
50,000
$1.1m0.66%
0.66%
Unchanged Shares held: Q3 2020 50.0k, Q4 2020 50.0k, Q1 2021 50.0k, Q2 2021 50.0k
29
OVINTIV INC
COM
OVV
OVV
34,200
$1.1m0.64%
0.64%
Reduced Shares held: Q3 2020 34.4k, Q4 2020 34.4k, Q1 2021 34.4k, Q2 2021 34.2k
-150
-150
-0.4%
30
SOLENO THERAPEUTICS INC
COM
COM
876,899
$1.0m0.60%
0.60%
Unchanged Shares held: Q3 2020 826.9k, Q4 2020 826.9k, Q1 2021 876.9k, Q2 2021 876.9k
31
BIOHAVEN PHARMACTL HLDG CO L
COM
BHVN
BHVN
10,000
$971.0k0.58%
0.58%
Unchanged Shares held: Q3 2020 10.0k, Q4 2020 10.0k, Q1 2021 10.0k, Q2 2021 10.0k
32
PROGENITY INC
COM
COM
270,000
$964.0k0.58%
0.58%
Unchanged Shares held: Q3 2020 0, Q4 2020 250.0k, Q1 2021 270.0k, Q2 2021 270.0k
33
KALVISTA PHARMACEUTICALS INC
COM
KALV
KALV
40,000
$958.0k0.57%
0.57%
Unchanged Shares held: Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 40.0k, Q2 2021 40.0k
34
PROGYNY INC
COM
PGNY
PGNY
15,000
$885.0k0.53%
0.53%
Unchanged Shares held: Q3 2020 15.0k, Q4 2020 15.0k, Q1 2021 15.0k, Q2 2021 15.0k
35
CONTRAFECT CORP
COM
CFRX
CFRX
200,000
$880.0k0.53%
0.53%
Unchanged Shares held: Q3 2020 255.7k, Q4 2020 200.0k, Q1 2021 200.0k, Q2 2021 200.0k
36
G1 THERAPEUTICS INC
COM
GTHX
GTHX
40,000
$878.0k0.53%
0.53%
Unchanged Shares held: Q3 2020 40.0k, Q4 2020 40.0k, Q1 2021 40.0k, Q2 2021 40.0k
37
TRANSLATE BIO INC
COM
COM
30,000
$826.0k0.49%
0.49%
Unchanged Shares held: Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 30.0k, Q2 2021 30.0k
38
INARI MED INC
COM
NARI
NARI
7,000
$653.0k0.39%
0.39%
Unchanged Shares held: Q3 2020 7.0k, Q4 2020 7.0k, Q1 2021 7.0k, Q2 2021 7.0k
39
TURNING POINT THERAPEUTICS I
COM
COM
8,000
$624.0k0.37%
0.37%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 8.0k
40
PIONEER NAT RES CO
COM
PXD
PXD
3,800
$618.0k0.37%
0.37%
Unchanged Shares held: Q3 2020 3.8k, Q4 2020 3.8k, Q1 2021 3.8k, Q2 2021 3.8k
41
TG THERAPEUTICS INC
COM
TGTX
TGTX
15,000
$582.0k0.35%
0.35%
Unchanged Shares held: Q3 2020 15.0k, Q4 2020 15.0k, Q1 2021 15.0k, Q2 2021 15.0k
42
ASPIRA WOMENS HEALTH INC
COM
COM
103,104
$579.0k0.35%
0.35%
Unchanged Shares held: Q3 2020 3.1m, Q4 2020 840.1k, Q1 2021 103.1k, Q2 2021 103.1k
43
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
8,000
$506.0k0.30%
0.30%
Unchanged Shares held: Q3 2020 8.0k, Q4 2020 8.0k, Q1 2021 8.0k, Q2 2021 8.0k
44
STOKE THERAPEUTICS INC
COM
STOK
STOK
15,000
$505.0k0.30%
0.30%
Unchanged Shares held: Q3 2020 20.0k, Q4 2020 20.0k, Q1 2021 15.0k, Q2 2021 15.0k
45
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
10,000
$449.0k0.27%
0.27%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 10.0k, Q2 2021 10.0k
46
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
8,000
$426.0k0.25%
0.25%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 8.0k
47
XENCOR INC
COM
XNCR
XNCR
12,300
$424.0k0.25%
0.25%
Unchanged Shares held: Q3 2020 12.3k, Q4 2020 12.3k, Q1 2021 12.3k, Q2 2021 12.3k
48
LAIRD SUPERFOOD INC
COM STK
LSF
LSF
14,000
$418.0k0.25%
0.25%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 14.0k, Q2 2021 14.0k
49
CHEMOCENTRYX INC
COM
CCXI
CCXI
30,000
$402.0k0.24%
0.24%
Unchanged Shares held: Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 30.0k, Q2 2021 30.0k
50
AKEBIA THERAPEUTICS INC
COM
AKBA
AKBA
100,000
$379.0k0.23%
0.23%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
51
DICERNA PHARMACEUTICALS INC
COM
DRNA
DRNA
10,000
$373.0k0.22%
0.22%
Unchanged Shares held: Q3 2020 10.0k, Q4 2020 10.0k, Q1 2021 10.0k, Q2 2021 10.0k
52
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
38,000
$366.0k0.22%
0.22%
Unchanged Shares held: Q3 2020 38.0k, Q4 2020 38.0k, Q1 2021 38.0k, Q2 2021 38.0k
53
SIENTRA INC
COM
SIEN
SIEN
40,000
$318.0k0.19%
0.19%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 40.0k
54
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
20,000
$316.0k0.19%
0.19%
Unchanged Shares held: Q3 2020 20.0k, Q4 2020 20.0k, Q1 2021 20.0k, Q2 2021 20.0k
55
ELUTIA INC
CL A COM
ELUT
ELUT
30,000
$288.0k0.17%
0.17%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 30.0k
56
KINIKSA PHARMACEUTICALS LTD
COM CL A
COM CL A
20,000
$279.0k0.17%
0.17%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 20.0k
57
ARCUTIS BIOTHERAPEUTICS INC
COM
ARQT
ARQT
9,000
$246.0k0.15%
0.15%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 9.0k, Q2 2021 9.0k
58
INFLARX NV
COM
IFRX
IFRX
70,000
$208.0k0.12%
0.12%
Unchanged Shares held: Q3 2020 70.0k, Q4 2020 70.0k, Q1 2021 70.0k, Q2 2021 70.0k
59
CYTOKINETICS INC
COM NEW
CYTK
CYTK
10,000
$198.0k0.12%
0.12%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 10.0k
60
HOOKIPA PHARMA INC
COM
COM
20,000
$183.0k0.11%
0.11%
New Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 20.0k
61
THERAPEUTICSMD INC
COM
TXMD
TXMD
100,000
$119.0k0.07%
0.07%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 100.0k, Q2 2021 100.0k
62
CONCERT PHARMACEUTICALS INC
COM
CNCE
CNCE
20,000
$84.0k0.05%
0.05%
Unchanged Shares held: Q3 2020 0, Q4 2020 0, Q1 2021 20.0k, Q2 2021 20.0k